Reaffirming the role of inflammasomes as a potential therapeutic target in the treatment of psoriasis [9], as with the NLRP3 inflammasome, researchers focused on finding substances that would silence or completely inhibit AIM-2 inflammasome activation in psoriasis. This evidence concerns the gene AIM2 and psoriasis.